Trial Profile
A Study to Assess the Clinical Effects of SCH 527123 in Psoriasis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 May 2022
Price :
$35
*
At a glance
- Drugs Navarixin (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Schering-Plough Research Institute
- 01 Oct 2013 Planned number of patients changed from 30 to 31.
- 11 Jun 2011 New trial record